TY - JOUR
T1 - The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease
AU - Matchett, Billie J.
AU - Grinberg, Lea T.
AU - Theofilas, Panos
AU - Murray, Melissa E.
N1 - Funding Information:
The investigators are supported by grants from the Alzheimer’s Association (AARG-17-533458); National Institute on Aging (LTG: R01 AG056573, K24 AG053435; PT: K01 AG053433; MEM: R01 AG054449, U01 AG57195, P30 AG062677); the Florida Department of Health, and the Ed and Ethel Moore Alzheimer’s Disease Research Program (8AZ06, 20a22); BrightFocus foundation; UCSF RAP Pilot Award; and a kind gift from David and Frances Strawn. We are grateful to Virginia Phillips, Ariston Librero, Jo Landino, and Monica Castanedes‐Casey for histologic support during figure development, and programmatic support by Samantha Davis. We would like to thank Dr. Peter Davies (Northwell Health’s Feinstein Institutes for Medical Research) for sharing the PHF-1 antibody.
Funding Information:
The investigators are supported by grants from the Alzheimer?s Association (AARG-17-533458); National Institute on Aging (LTG: R01 AG056573, K24 AG053435; PT: K01 AG053433; MEM: R01 AG054449, U01 AG57195, P30 AG062677); the Florida Department of Health, and the Ed and Ethel Moore Alzheimer?s Disease Research Program (8AZ06, 20a22); BrightFocus foundation; UCSF RAP Pilot Award; and a kind gift from David and Frances Strawn. We are grateful to Virginia Phillips, Ariston Librero, Jo Landino, and Monica Castanedes?Casey for histologic support during figure development, and programmatic support by Samantha Davis. We would like to thank Dr. Peter Davies (Northwell Health?s Feinstein Institutes for Medical Research) for sharing the PHF-1 antibody.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/5
Y1 - 2021/5
N2 - Alzheimer’s disease (AD) is neuropathologically characterized by the intracellular accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β plaques, which affect certain brain regions in a progressive manner. The locus coeruleus (LC), a small nucleus in the pons of the brainstem, is widely recognized as one of the earliest sites of neurofibrillary tangle formation in AD. Patients with AD exhibit significant neuronal loss in the LC, resulting in a marked reduction of its size and function. The LC, which vastly innervates several regions of the brain, is the primary source of the neurotransmitter norepinephrine (NE) in the central nervous system. Considering that NE is a major modulator of behavior, contributing to neuroprotection and suppression of neuroinflammation, degeneration of the LC in AD and the ultimate dysregulation of the LC–NE system has detrimental effects in the brain. In this review, we detail the neuroanatomy and function of the LC, its essential role in neuroprotection, and how this is dysregulated in AD. We discuss AD-related neuropathologic changes in the LC and mechanisms by which LC neurons are selectively vulnerable to insult. Further, we elucidate the neurotoxic effects of LC de-innervation both locally and at projection sites, and how this augments disease pathology, progression and severity. We summarize how preservation of the LC–NE system could be used in the treatment of AD and other neurodegenerative diseases affected by LC degeneration.
AB - Alzheimer’s disease (AD) is neuropathologically characterized by the intracellular accumulation of hyperphosphorylated tau and the extracellular deposition of amyloid-β plaques, which affect certain brain regions in a progressive manner. The locus coeruleus (LC), a small nucleus in the pons of the brainstem, is widely recognized as one of the earliest sites of neurofibrillary tangle formation in AD. Patients with AD exhibit significant neuronal loss in the LC, resulting in a marked reduction of its size and function. The LC, which vastly innervates several regions of the brain, is the primary source of the neurotransmitter norepinephrine (NE) in the central nervous system. Considering that NE is a major modulator of behavior, contributing to neuroprotection and suppression of neuroinflammation, degeneration of the LC in AD and the ultimate dysregulation of the LC–NE system has detrimental effects in the brain. In this review, we detail the neuroanatomy and function of the LC, its essential role in neuroprotection, and how this is dysregulated in AD. We discuss AD-related neuropathologic changes in the LC and mechanisms by which LC neurons are selectively vulnerable to insult. Further, we elucidate the neurotoxic effects of LC de-innervation both locally and at projection sites, and how this augments disease pathology, progression and severity. We summarize how preservation of the LC–NE system could be used in the treatment of AD and other neurodegenerative diseases affected by LC degeneration.
KW - Alzheimer’s disease
KW - Locus coeruleus
KW - Norepinephrine
KW - Selective vulnerability
KW - Tau
UR - http://www.scopus.com/inward/record.url?scp=85099382256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099382256&partnerID=8YFLogxK
U2 - 10.1007/s00401-020-02248-1
DO - 10.1007/s00401-020-02248-1
M3 - Review article
C2 - 33427939
AN - SCOPUS:85099382256
SN - 0001-6322
VL - 141
SP - 631
EP - 650
JO - Acta neuropathologica
JF - Acta neuropathologica
IS - 5
ER -